Where does Semprus Biosciences Corp. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Semprus Biosciences Corp. ranks #37,406 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Semprus Biosciences Corp. hold?

Semprus Biosciences Corp. holds 7 US utility patents granted between 2015 and 2018, spanning 13 technology areas.

What is Semprus Biosciences Corp.'s Innovation Score?

Semprus Biosciences Corp. has an Innovation Score of 32.6 out of 100 (42nd percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Semprus Biosciences Corp.'s patent grant rate increasing or decreasing?

Semprus Biosciences Corp.'s recent grant velocity is -100% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Semprus Biosciences Corp.'s patents?

Semprus Biosciences Corp.'s patents average 21.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Semprus Biosciences Corp. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Semprus Biosciences Corp.

Q: What technology areas does Semprus Biosciences Corp. focus on?

Semprus Biosciences Corp.'s top technology area is C08G (Macromolecular Compounds Obtained Otherwise Than BY Reactions Only Involving Unsaturated Carbon-to-carbon Bonds) with 3 patents, ranking #800 of 1,741 assignees active in that subclass. Grants appear in 13 CPC subclasses total.

USPTO PatentsView assignee record - 7 granted patents across 13 technology areas, recorded in grant years 2015–2018. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C08G (Macromolecular Compounds Obtained Otherwise Than BY Reactions Only Involving Unsaturated Carbon-to-carbon Bonds).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Semprus ranks #37,406 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 13 technology areas.

#37,406
of 49,997 US assignees by volume: 42nd percentile
by Innovation Score (32.6/100): 21.1
avg claims per patent: -100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R37406 · US Corporation #37,406 · 7 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 7 grants
MID-PACK #37,406/49,997
PHOTO-FINISH Secure Medication…
CPC-FOCUS C08G · 13 areas
INNOV-THIN 32.6/100
CLAIMS-DENSE 21.1 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Secure Medication Systems, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Semprus’s 32.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.2 pts (22%) Velocity 0.0 pts (0%) Breadth 12.7 pts (39%) Claim depth 12.7 pts (39%)

Qualcomm Incorporated · highest

85
Semprus Biosciences · this assignee

33
3D Lighting… · lowest

7

What this shows Semprus's Innovation Score is 32.6/100 (42nd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Semprus?

Each dot is one of Semprus’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Semprus’s own 21.1 claims/patent is ABOVE the 12.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Semprus vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Semprus's grants concentrate

Semprus Biosciences Corp. is a focused PatentsView assignee: 13 CPC subclasses with 42.9% of grants classified under C08G (Macromolecular Compounds Obtained Otherwise Than BY Reactions Only Involving Unsaturated Carbon-to-carbon Bonds). Peak complete grant year is 2015 (5 grants) versus a trough of 1 in 2017. By volume, Semprus sits between Secure Medication Systems, LLC and Sensor Platforms, Inc..

Secure Medication…

7
Sedation Systems

7
Segars California…

7
Semiwise

7
Senex Biotechnolo…

7
Sensable

7
Sensogram

7
Sensor Platforms

7
Semprus Bioscienc… ◀

7

What this shows Semprus holds 7 patents at rank #37,574, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Semprus

By rank, the assignees closest to #37,574 in granted patent volume.

Leaders in C08G (Macromolecular Compounds Obtained Otherwise Than BY React…)

Other assignees with the most granted patents in Semprus's primary technology class.

Semprus's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

33 42nd percentile higher than 42% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2018

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Semprus Biosciences Corp. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	5	71.4%
2017	1	14.3%
2018	1	14.3%

Which technologies does Semprus Biosciences Corp. patent most?

C08G - Macromolecular Compounds Obtained Otherwise Than BY Reactions Only Involving Unsaturated Carbon-to-carbon Bonds 3

G02B - Optical Elements, Systems OR Apparatus 3

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 3

C08F - Macromolecular Compounds Obtained BY Reactions Only Involving Carbon-to-carbon Unsaturated Bonds 3

Y10T - Technical Subjects Covered BY Former US Classification 3

C09D - Coating Compositions, e.g. Paints, Varnishes OR LACQUERS; Filling PASTES; Chemical Paint OR INK REMOVERS; INKS; Correcting FLUIDS; WOODSTAINS; Pastes OR Solids FOR Colouring OR PRINTING; USE OF Materials Therefor 2

G02C - SPECTACLES; Sunglasses OR Goggles Insofar AS They Have THE Same Features AS SPECTACLES; Contact Lenses 2

B05D - Processes FOR Applying Fluent Materials TO Surfaces, IN General 2

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 1

C08L - Compositions OF Macromolecular Compounds 1

B29D - Producing Particular Articles From Plastics OR From Substances IN A Plastic State 1

C08K - Use of inorganic or non-macromolecular organic substances as compounding ingredients 1

C08J - WORKING-UP; General Processes OF COMPOUNDING; After-treatment NOT Covered BY Subclasses C08b, C08c, C08f, C08g or C08h 1

Top 13 of 13 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Semprus Biosciences Corp.'s patent record in context - here's where to go next.

Semprus Biosciences Corp.'s lead technology class is C08G (Macromolecular Compounds Obtained Otherwise Than BY Reactions Only Involving Unsaturated Carbon-to-carbon Bonds), 42.9% of its portfolio - see every assignee active in that class. Explore C08G
Ranked #37,406 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Semprus Biosciences Corp. against Secure Medication Systems, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 32.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.